SCHEMBL29097022

SCHEMBL29097022

Cc1cc2c(C(=O)OCc3ccccc3)c(OC[C@@H](Cc3ccccc3)NC(=O)OC(C)(C)C)ccc2cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.43
▸ SYK P43405 1/20 0.42
▸ AAK1 Q2M2I8 2/20 0.40
▸ KLK5 Q9Y337 1/20 0.39
▸ HDAC3 O15379 2/20 0.39
▸ HDAC4 P56524 2/20 0.39
▸ HDAC1 Q13547 2/20 0.39
▸ HDAC7 Q8WUI4 2/20 0.39
▸ HDAC2 Q92769 2/20 0.39
▸ HDAC10 Q969S8 2/20 0.39
▸ HDAC11 Q96DB2 2/20 0.39
▸ HDAC8 Q9BY41 2/20 0.39
▸ HDAC6 Q9UBN7 2/20 0.39
▸ HDAC9 Q9UKV0 2/20 0.39
▸ HDAC5 Q9UQL6 2/20 0.39
▸ MAPT P10636 2/20 0.38
▸ CTRB1 P17538 2/20 0.38
▸ CYP3A4 P08684 5/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ APP P05067 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29828533 1.00 ATM (0.43) ATMSYKAAK1KLK5HDAC3
SCHEMBL29097024 1.00 ATM (0.43) ATMSYKAAK1KLK5HDAC3
SCHEMBL27032864 0.91 ATM (0.47) ATMAAK1HDAC3HDAC4HDAC1
SCHEMBL27135967 0.91 ATM (0.47) ATMAAK1HDAC3HDAC4HDAC1
SCHEMBL29096959 0.85 ATM (0.47) ATMAAK1KLK5HDAC3HDAC4
SCHEMBL29828809 0.85 ATM (0.47) ATMAAK1KLK5HDAC3HDAC4
SCHEMBL30639523 0.85 ATM (0.47) ATMAAK1KLK5HDAC3HDAC4
SCHEMBL30790785 0.83 ATM (0.43) ATMSYKAAK1KLK5HDAC3
SCHEMBL30878142 0.82 ATM (0.47) ATMSYKMAPTCTRB1CYP3A4
SCHEMBL29097301 0.82 ATM (0.47) ATMSYKAAK1KLK5HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116981672-A Macrocyclic compounds as CFTR modulators 爱杜西亚药品有限公司 2023-10-31 — — CN disclosed
Send feedback